It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2016.
2016 | Jaipur, Rajasthan, India | ActiveMedorb Pharmaceutical Private Limited, a active private limited company, was established on 05 September 2016 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290RJ2016PTC055894. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sharda Devi Meena (Director), Sunil Kumar Kothiwala (Director). Past directors included Amit Kumar, Phool Wanti Mehta, Yogendra Sharma. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot Num 08 First Floor, New Colony, Near Railway Line, Jaipur, Rajasthan, 302017.
U24290RJ2016PTC055894
055894
05 September 2016
₹0.10 M
₹0.10 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Medorb Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sharda Devi Meena | Director | 19 Jun 2017 | Current |
| Sunil Kumar Kothiwala | Director | 01 May 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Sep 2019 | Past |
| Pramod Abcsdd | Director | 19 Sep 2019 | Past |
| Pramod Abcsdd | Director | 01 May 2021 | Past |
| Pramod Abcsdd | Director | 19 Sep 2019 | Past |
| Pramod Abcsdd | Director | 19 Jun 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medorb Pharmaceutical Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.28% decrease. The company also saw a substantial fall in profitability, with a 310.42% decrease in profit. The company's net worth observed a substantial decline by a decrease of 82.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Medorb Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medorb Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medorb Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medorb Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medorb Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Medorb Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was recorded as a recent event.
The activity Sunil Kumar Kothiwala was appointed as a Director was appointed as a Director on 01 May 2021 & has been associated with this company since 4 years 7 months . was completed.
Sharda Devi Meena was appointed as a Director was appointed as a Director on 19 Jun 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.
The activity Medorb Pharmaceutical Private Limited was registered on 05 Sep 2016 with Roc Jaipur & aged 9 years 3 months as per MCA records. was completed.
The CIN of Medorb Pharmaceutical Private Limited is U24290RJ2016PTC055894.
Medorb Pharmaceutical Private Limited is headquartered at Plot Num 08 First Floor, New Colony, Near Railway Line, Jaipur, Rajasthan, 302017.
Medorb Pharmaceutical Private Limited was incorporated on 05 September 2016.
The current directors of Medorb Pharmaceutical Private Limited are
The primary industry of Medorb Pharmaceutical Private Limited is Pharma.
Medorb Pharmaceutical Private Limited is unlisted.
The authorized capital of Medorb Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medorb Pharmaceutical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX